CoreCap Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Buy |
3,140
+338
| +12% | +$13K | ﹤0.01% | 918 |
|
|
2025
Q1 | $109K | Buy |
2,802
+717
| +34% | +$27.8K | ﹤0.01% | 875 |
|
|
2024
Q4 | $70.5K | Buy |
2,085
+104
| +5% | +$3.52K | ﹤0.01% | 1046 |
|
|
2024
Q3 | $81K | Sell |
1,981
-573
| -22% | -$23.4K | ﹤0.01% | 1004 |
|
|
2024
Q2 | $98.3K | Buy |
2,554
+481
| +23% | +$18.5K | 0.01% | 505 |
|
|
2024
Q1 | $88.9K | Buy |
+2,073
| New | +$88.9K | ﹤0.01% | 880 |
|
|
2022
Q4 | $70.1K | Buy |
+1,996
| New | +$70.1K | 0.01% | 865 |
|
|
2022
Q3 | – | Sell |
-1,203
| Closed | -$66K | – | 1154 |
|
|
2022
Q2 | $66K | Buy |
+1,203
| New | +$66K | 0.01% | 847 |
|
|
2022
Q1 | – | Sell |
-1,992
| Closed | -$110K | – | 1155 |
|
|
2021
Q4 | $110K | Buy |
+1,992
| New | +$110K | 0.01% | 720 |
|